• TMA Myositis Research Insights Webinar featuring Dr. Julio Huapaya

    Virtual Event
    Webinar

    Join us for an insightful session with Julio Huapaya, MD, a critical care and pulmonary specialist affiliated with Johns Hopkins Medicine and the NIH Clinical Center. Dr. Huapaya's talk will dive into his cutting-edge research on myositis-associated interstitial lung disease (M‑ILD), focusing on: Longitudinal clinical features and outcomes in patients with anti‑synthetase syndrome autoantibodies, based...

  • TMA Empowerment Clinic: From Diagnosis to Determined: Grace, Grit, and Getting Back Up

    Virtual Event
    Webinar

    Join TEDx speaker and founder of The disABLED Company™, Alicia Polak, for a powerful and uplifting Empowerment Clinic as she shares her personal journey with Inclusion Body Myositis. Through relatable stories, moments of levity, and lessons in self-advocacy, Alicia will explore how a mindset rooted in being Able, Authentic, and Adaptive can transform the experience...

  • TMA Ask the Expert: Cell Therapy Edition

    Virtual Event
    Webinar

    TMA’s Ask the Expert webinar series gives members of the myositis community direct access to leading experts in the field. Each session features a trusted medical professional who answers your questions about specific types of myositis, treatment options, research developments, and disease management. August’s Ask the Expert webinar features Iazsmin Bauer Ventura, MD, a clinician...

  • Ask the Expert featuring Astia Allenzara, MD, MCSR

    Virtual Event
    Webinar

    Register Here 💬 Your questions, answered by a myositis expert! Ask the Expert with Dr. Astia AllenzaraJoin us on Monday, September 8 at 12:00 PM ET / 6:00 PM CEST for a special Ask the Expert session featuring Astia Allenzara, MD, MSCR, an internist and rheumatologist at UNC Chapel Hill. Dr. Allenzara’s work focuses on...

  • Understanding Clinical Trials

    Virtual Event
    Webinar

    Register Here Clinical trials are conducted to evaluate the safety, efficacy, and outcomes of medical interventions to ensure that treatments brought to market are based on robust evidence and provide benefits to patients. This session will explore lessons from history (both good and bad), global standards for clinical studies, the drug development process, and what...